Quick Heal Technologies · NSE: QUICKHEAL · BSE: 539678
Q4 FY26 results · Jan–Mar 2026
Quick Heal Technologies reported revenue from operations of ₹48.73 crore (down 25.2% from Q4 FY25) and net loss of ₹19.94 crore for Q4 FY26 (Jan–Mar 2026), on a consolidated basis.
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 48.73 | 65.14 | −25.2% | 71.54 | −31.9% |
| Other income | 3.75 | 5.60 | −33.0% | 8.95 | −58.1% |
| Total income | 52.48 | 70.74 | −25.8% | 80.49 | −34.8% |
| Profit before tax | (29.67) | (6.57) | Loss widened | 5.75 | Turned loss |
| Net profit for the period | (19.94) | (3.25) | Loss widened | 6.61 | Turned loss |
| EPS, basic (₹) | (3.58) | (0.60) | Loss widened | 1.19 | Turned loss |
| Net margin (%) | -40.9 | -5.0 | 9.2 |
| Item | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 48.77 | 65.13 | −25.1% | 71.54 | −31.8% |
| Other income | 3.70 | 5.54 | −33.2% | 8.86 | −58.2% |
| Total income | 52.47 | 70.67 | −25.8% | 80.40 | −34.7% |
| Profit before tax | (29.64) | (6.00) | Loss widened | 6.00 | Turned loss |
| Net profit for the period | (19.91) | (2.68) | Loss widened | 6.86 | Turned loss |
| EPS, basic (₹) | (3.58) | (0.50) | Loss widened | 1.23 | Turned loss |
| Net margin (%) | -40.8 | -4.1 | 9.6 |
Consolidated
- Filed with BSE
- 27 May 2026, 17:48 IST
- Board meeting
- 21 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 27 May 2026, 17:48 IST
- Board meeting
- 21 May 2026
- Period
- 01 Jan 2026 to 31 Mar 2026
- Review status
- Audited
- Source
- XBRL filing on BSE